Literature DB >> 11134330

Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.

J I Leu1, M A Crissey, J P Leu, G Ciliberto, R Taub.   

Abstract

Following hepatic injury or stress, gluconeogenic and acute-phase response genes are rapidly upregulated to restore metabolic homeostasis and limit tissue damage. Regulation of the liver-restricted insulin-like growth factor binding protein 1 (IGFBP-1) gene is dramatically altered by changes in the metabolic state and hepatectomy, and thus it provided an appropriate reporter to assess the transcriptional milieu in the liver during repair and regeneration. The cytokine interleukin-6 (IL-6) is required for liver regeneration and repair, and it transcriptionally upregulates a vast array of genes during liver growth by unknown mechanisms. Evidence for a biologic role of IL-6 in IGFBP-1 upregulation was demonstrated by increased expression of hepatic IGFBP-1 in IL-6 transgenic and following injection of IL-6 into nonfasting animals and its reduced expression in IL-6(-/-) livers posthepatectomy. In both hepatic and nonhepatic cells, IL-6 -mediated IGFBP-1 promoter activation was via an intact hepatocyte nuclear factor 1 (HNF-1) site and was dependent on the presence of endogenous liver factor HNF-1 and induced factors STAT3 and AP-1 (c-Fos/c-Jun). IL-6 acted through the STAT3 pathway, as dominant negative STAT3 completely blocked IL-6-mediated stimulation of the IGFBP-1 promoter via the HNF-1 site. HNF-1/c-Fos and HNF-1/STAT3 protein complexes were detected in mouse livers and in hepatic and nonhepatic cell lines overexpressing STAT3/c-Fos/HNF-1. Similar regulation was demonstrated using glucose-6-phosphatase and alpha-fibrinogen promoters, indicating that HNF-1/IL-6/STAT3/AP-1-mediated transactivation of hepatic gene expression is a general phenomenon after liver injury. These results demonstrate that the two classes of transcription factors, growth induced (STAT3 and AP-1) and tissue specific (HNF-1), can interact as an adaptive response to liver injury to amplify expression of hepatic genes important for the homeostatic response during organ repair.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134330      PMCID: PMC86585          DOI: 10.1128/MCB.21.2.414-424.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation.

Authors:  X Zhang; M H Wrzeszczynska; C M Horvath; J E Darnell
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 2.  Regulation of glucose production by the liver.

Authors:  R C Nordlie; J D Foster; A J Lange
Journal:  Annu Rev Nutr       Date:  1999       Impact factor: 11.848

Review 3.  Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration.

Authors:  R Taub; L E Greenbaum; Y Peng
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

4.  Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells. Liver-specific induction patterns of gene 33, phosphoenolpyruvate carboxykinase, and the jun, fos, and egr families.

Authors:  K L Mohn; T M Laz; A E Melby; R Taub
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

5.  The HNF-4/HNF-1alpha transactivation cascade regulates gene activity and chromatin structure of the human serine protease inhibitor gene cluster at 14q32.1.

Authors:  P Rollini; R E Fournier
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

6.  The gene encoding rat insulinlike growth factor-binding protein 1 is rapidly and highly induced in regenerating liver.

Authors:  K L Mohn; A E Melby; D S Tewari; T M Laz; R Taub
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

7.  The promoter of the human gene for insulin-like growth factor binding protein-1. Basal promoter activity in HEP G2 cells depends upon liver factor B1.

Authors:  A Suwanichkul; M L Cubbage; D R Powell
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

8.  Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

Authors:  L Ulloa; J Doody; J Massagué
Journal:  Nature       Date:  1999-02-25       Impact factor: 49.962

9.  Interplay of the liver-enriched trans-acting factors, DBP and HNF1, in the transactivation of human IGFBP-1 promoter.

Authors:  S Babajko; A Groyer
Journal:  Biochem Biophys Res Commun       Date:  1993-10-15       Impact factor: 3.575

10.  Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites.

Authors:  C Toniatti; A Demartis; P Monaci; A Nicosia; G Ciliberto
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

View more
  41 in total

1.  Hepatoprotection via the IL-6/Stat3 pathway.

Authors:  Rebecca Taub
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

2.  Gene expression during the priming phase of liver regeneration after partial hepatectomy in mice.

Authors:  Andrew I Su; Luca G Guidotti; John Paul Pezacki; Francis V Chisari; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

3.  Disrupted NF- kappa B activation after partial hepatectomy does not impair hepatocyte proliferation in rats.

Authors:  Stéphanie Laurent; Yves Horsmans; Peter Stärkel; Isabelle Leclercq; Christine Sempoux; Luc Lambotte
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

4.  Activation of inactive hepatocytes through histone acetylation: a mechanism for functional compensation after massive loss of hepatocytes.

Authors:  Yujun Shi; Huaiqiang Sun; Ji Bao; Ping Zhou; Jie Zhang; Li Li; Hong Bu
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

5.  Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells.

Authors:  Douglas Edmund Feldman; Chialin Chen; Vasu Punj; Hidekazu Tsukamoto; Keigo Machida
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-29       Impact factor: 11.205

6.  Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression.

Authors:  Meena B Bansal; Kellen Kovalovich; Ritu Gupta; Wei Li; Akansha Agarwal; Brian Radbill; Carlos E Alvarez; Rifaat Safadi; M Isabel Fiel; Scott L Friedman; Rebecca A Taub
Journal:  J Hepatol       Date:  2005-04       Impact factor: 25.083

7.  A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals.

Authors:  Cleide G da Silva; Peter Studer; Marco Skroch; Jerome Mahiou; Darlan C Minussi; Clayton R Peterson; Suzhuei W Wilson; Virendra I Patel; Averil Ma; Eva Csizmadia; Christiane Ferran
Journal:  Hepatology       Date:  2013-04-05       Impact factor: 17.425

8.  Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation.

Authors:  Julia I Leu; Mary Ann S Crissey; Linden E Craig; Rebecca Taub
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

9.  IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters.

Authors:  Kenneth M Andrejko; Nichelle R Raj; Patrick K Kim; Maurizio Cereda; Clifford S Deutschman
Journal:  Shock       Date:  2008-04       Impact factor: 3.454

10.  Temporal and functional profile of the transcriptional regulatory network in the early regenerative response to partial hepatectomy in the rat.

Authors:  Egle Juskeviciute; Rajanikanth Vadigepalli; Jan B Hoek
Journal:  BMC Genomics       Date:  2008-11-06       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.